-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Relay Therapeutics, Inc. annual/quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2022.
- Relay Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2022 was 111 M shares, a 19.6% increase year-over-year.
- Relay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 112 M shares, a 18% increase from 2021.
- Relay Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 95.1 M shares, a 123% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)